Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Beryl Drugs

Sector: Healthcare | Industry: Drugs & Pharma
R 4.60 -0.07  | -1.50% -54.00% 3.19 2.33
BSE Price: Oct 14, 16:01 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Oct 14, 16:01 4.60 -0.07 -1.50% 4.44 4.67 110 4.44 - 4.60
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 1,019 P/B: 0.30 NSE Code:
52-Week Range: R 3.59 - 12.00 Dividend Yield: 0.00% BSE Code: 524606
TTM EPS: R 1.44 Book Value: R 15.48 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Beryl Drugs -48.68 23.87 -30.40 -50.84 -34.97 -32.13 -4.77
S&P BSE Small Cap -13.15 -0.93 -7.15 -7.45 -1.23 3.77 5.64
S&P BSE Healthcare -12.72 -6.94 -5.50 -15.31 -9.36 -2.37 10.68
Company's return has been calculated on basis of BSE's price.
As on Oct 11, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 37.75 4.46 0.68
Net Profit 751.52 127.41 20.55
EPS 751.52 127.41 20.50
Book Value -1.88 0.88 1.61
Average
Operating Margin 11.46 8.32 7.66
Net Margin 6.27 2.85 2.19
Return on Networth 14.80 6.36 4.93
Return on Investment 16.88 8.97 8.04
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 75.72 1.10 1.22
Operating Profit 195.48 50.38 -36.29
Net Profit 233.01 69.80 36.65
EPS 232.99 69.80 36.63
TTM
Revenue 0.35 -13.08 -16.89
Operating Profit 15.21 -17.75 -11.66
Net Profit 23.90 -33.42 -26.38
EPS 23.90 14.03 36.37
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Beryl Drugs 2.33 13.25 0.73 5.51 14.80 0.30 3.19
Astrazeneca Pharma India 5,444.13 771.42 69.56 8.84 20.03 17.00 78.26
Eris Lifesciences 5,931.23 1,005.70 303.64 29.29 28.96 4.81 19.54
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jun 06, 2013 Sangita Sethi  Buy Market 50,000 25.85 12.93
May 30, 2013 Sonia Sethi  Buy Market 25,000 27.00 6.75
News & Announcements
Contact Information

Company: Beryl Drugs Ltd.

Address: 133, Kanchan Bagh, Indore, Madhya Pradesh - 452001 | Phone: 07292- 5065375 | Fax: 07292- 503295

Email: [email protected]

Registrar & Transfer Agent: Adroit Corporate Services Pvt Ltd

Address: 17-20 Jaferbhoy Industrial Estate , 1st Floor,Makwana Road,Marol Naka,Mumbai, 17-20 Jaferbhoy Industrial Estate , 1st Floor, Makwana Road, Marol Naka | Phone: 022-42270400 | Fax: 022-28503748

Email: [email protected]

Website: www.adroitcorporate.com

Essential checks
Altman Z-Score
2.46
Piotroski F-Score
7
Modified C-Score
2
5-Years Price to Earnings
3.24
5-Years Price to Book
0.30
Earnings Yield
EBIT / Enterprise value
31.38%
PEG
Price / Earnings to growth ratio
0.14
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,170.35 -1.31%
Caplin Point Laboratories R402.05 +0.59%
Eris Lifesciences R432.25 +1.02%
FDC R160.15 -1.84%
JB Chemicals & Pharma R359.50 -0.26%
Laurus Labs R319.90 -2.04%
Strides Pharma Science R338.50 +4.35%
Sun Pharma Adv. Research R118.85 +2.59%
Suven Life Sciences R258.20 +0.12%
Wockhardt R253.70 +1.20%
As on Oct 14, 15:59